Planning benchmark study for SBRT of early stage NSCLC

PurposeThe aim was to evaluate stereotactic body radiation therapy (SBRT) treatment planning variability for early stage nonsmall cell lung cancer (NSCLC) with respect to the published guidelines of the Stereotactic Radiotherapy Working Group of the German Society for Radiation Oncology (DEGRO).Mate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Moustakis, Christos (VerfasserIn) , Blanck, Oliver (VerfasserIn) , Sterzing, Florian (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 31 May 2017
In: Strahlentherapie und Onkologie
Year: 2017, Jahrgang: 193, Heft: 10, Pages: 780-790
ISSN:1439-099X
DOI:10.1007/s00066-017-1151-8
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1007/s00066-017-1151-8
Verlag, Volltext: https://link.springer.com/article/10.1007/s00066-017-1151-8
Volltext
Verfasserangaben:Christos Moustakis, Oliver Blanck, Fatemeh Ebrahimi Tazehmahalleh, Mark ka heng Chan, Iris Ernst, Thomas Krieger, Marciana-Nona Duma, Markus Oechsner, Ute Ganswindt, Christian Heinz, Horst Alheit, Hilbert Blank, Ursula Nestle, Rolf Wiehle, Christine Kornhuber, Christian Ostheimer, Cordula Petersen, Gerhard Pollul, Wolfgang Baus, Georg Altenstein, Eric Beckers, Katrin Jurianz, Florian Sterzing, Matthias Kretschmer, Heinrich Seegenschmiedt, Torsten Maass, Stefan Droege, Ulrich Wolf, Juergen Schoeffler, Uwe Haverkamp, Hans Theodor Eich, Matthias Guckenberger

MARC

LEADER 00000caa a2200000 c 4500
001 1575432072
003 DE-627
005 20220814144127.0
007 cr uuu---uuuuu
008 180523s2017 xx |||||o 00| ||eng c
024 7 |a 10.1007/s00066-017-1151-8  |2 doi 
035 |a (DE-627)1575432072 
035 |a (DE-576)505432072 
035 |a (DE-599)BSZ505432072 
035 |a (OCoLC)1341009996 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Moustakis, Christos  |d 1970-  |e VerfasserIn  |0 (DE-588)122453476  |0 (DE-627)705914240  |0 (DE-576)293278245  |4 aut 
245 1 0 |a Planning benchmark study for SBRT of early stage NSCLC  |c Christos Moustakis, Oliver Blanck, Fatemeh Ebrahimi Tazehmahalleh, Mark ka heng Chan, Iris Ernst, Thomas Krieger, Marciana-Nona Duma, Markus Oechsner, Ute Ganswindt, Christian Heinz, Horst Alheit, Hilbert Blank, Ursula Nestle, Rolf Wiehle, Christine Kornhuber, Christian Ostheimer, Cordula Petersen, Gerhard Pollul, Wolfgang Baus, Georg Altenstein, Eric Beckers, Katrin Jurianz, Florian Sterzing, Matthias Kretschmer, Heinrich Seegenschmiedt, Torsten Maass, Stefan Droege, Ulrich Wolf, Juergen Schoeffler, Uwe Haverkamp, Hans Theodor Eich, Matthias Guckenberger 
264 1 |c 31 May 2017 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 23.05.2018 
520 |a PurposeThe aim was to evaluate stereotactic body radiation therapy (SBRT) treatment planning variability for early stage nonsmall cell lung cancer (NSCLC) with respect to the published guidelines of the Stereotactic Radiotherapy Working Group of the German Society for Radiation Oncology (DEGRO).Materials and methodsPlanning computed tomography (CT) scan and the structure sets (planning target volume, PTV; organs at risk, OARs) of 3 patients with early stage NSCLC were sent to 22 radiotherapy departments with SBRT experience: each department was asked to prepare a treatment plan according to the DEGRO guidelines. The prescription dose was 3 fractions of 15 Gy to the 65% isodose.ResultsIn all, 87 plans were generated: 36 used intensity-modulated arc therapy (IMAT), 21 used three-dimensional conformal radiation therapy (3DCRT), 6 used static field intensity-modulated radiation therapy (SF-IMRT), 9 used helical radiotherapy and 15 used robotic radiosurgery. PTV dose coverage and simultaneously kept OARs doses were within the clinical limits published in the DEGRO guidelines. However, mean PTV dose (mean 58.0 Gy, range 52.8-66.4 Gy) and dose conformity indices (mean 0.75, range 0.60-1.00) varied between institutions and techniques (p ≤ 0.02). OARs doses varied substantially between institutions, but appeared to be technique independent (p = 0.21).ConclusionAll studied treatment techniques are well suited for SBRT of early stage NSCLC according to the DEGRO guidelines. Homogenization of SBRT practice in Germany is possible through the guidelines; however, detailed treatment plan characteristics varied between techniques and institutions and further homogenization is warranted in future studies and recommendations. Optimized treatment planning should always follow the ALARA (as low as reasonably achievable) principle. 
700 1 |a Blanck, Oliver  |e VerfasserIn  |0 (DE-588)115998106X  |0 (DE-627)1023098768  |0 (DE-576)505430649  |4 aut 
700 1 |a Sterzing, Florian  |d 1979-  |e VerfasserIn  |0 (DE-588)130141488  |0 (DE-627)492502722  |0 (DE-576)298021781  |4 aut 
773 0 8 |i Enthalten in  |t Strahlentherapie und Onkologie  |d Berlin : Springer Medizin, 1997  |g 193(2017), 10, Seite 780-790  |h Online-Ressource  |w (DE-627)312407866  |w (DE-600)2003907-4  |w (DE-576)090884809  |x 1439-099X  |7 nnas  |a Planning benchmark study for SBRT of early stage NSCLC 
773 1 8 |g volume:193  |g year:2017  |g number:10  |g pages:780-790  |g extent:11  |a Planning benchmark study for SBRT of early stage NSCLC 
856 4 0 |u http://dx.doi.org/10.1007/s00066-017-1151-8  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://link.springer.com/article/10.1007/s00066-017-1151-8  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180523 
993 |a Article 
994 |a 2017 
998 |g 130141488  |a Sterzing, Florian  |m 130141488:Sterzing, Florian  |d 910000  |d 911400  |e 910000PS130141488  |e 911400PS130141488  |k 0/910000/  |k 1/910000/911400/  |p 23 
999 |a KXP-PPN1575432072  |e 3009987269 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"given":"Christos","role":"aut","display":"Moustakis, Christos","family":"Moustakis"},{"family":"Blanck","display":"Blanck, Oliver","role":"aut","given":"Oliver"},{"display":"Sterzing, Florian","family":"Sterzing","given":"Florian","role":"aut"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"relHost":[{"id":{"zdb":["2003907-4"],"issn":["1439-099X"],"eki":["312407866"]},"title":[{"subtitle":"journal of radiation oncology, biology, physics","title_sort":"Strahlentherapie und Onkologie","title":"Strahlentherapie und Onkologie"}],"physDesc":[{"extent":"Online-Ressource"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["Nachgewiesen 173.1997 -"],"disp":"Planning benchmark study for SBRT of early stage NSCLCStrahlentherapie und Onkologie","note":["Gesehen am 13.05.09"],"part":{"issue":"10","pages":"780-790","volume":"193","year":"2017","text":"193(2017), 10, Seite 780-790","extent":"11"},"language":["ger"],"recId":"312407866","origin":[{"publisherPlace":"Berlin ; Heidelberg ; [München]","publisher":"Springer Medizin ; Urban & Vogel","dateIssuedDisp":"1997-","dateIssuedKey":"1997"}]}],"physDesc":[{"extent":"11 S."}],"title":[{"title":"Planning benchmark study for SBRT of early stage NSCLC","title_sort":"Planning benchmark study for SBRT of early stage NSCLC"}],"id":{"eki":["1575432072"],"doi":["10.1007/s00066-017-1151-8"]},"name":{"displayForm":["Christos Moustakis, Oliver Blanck, Fatemeh Ebrahimi Tazehmahalleh, Mark ka heng Chan, Iris Ernst, Thomas Krieger, Marciana-Nona Duma, Markus Oechsner, Ute Ganswindt, Christian Heinz, Horst Alheit, Hilbert Blank, Ursula Nestle, Rolf Wiehle, Christine Kornhuber, Christian Ostheimer, Cordula Petersen, Gerhard Pollul, Wolfgang Baus, Georg Altenstein, Eric Beckers, Katrin Jurianz, Florian Sterzing, Matthias Kretschmer, Heinrich Seegenschmiedt, Torsten Maass, Stefan Droege, Ulrich Wolf, Juergen Schoeffler, Uwe Haverkamp, Hans Theodor Eich, Matthias Guckenberger"]},"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"31 May 2017"}],"language":["eng"],"recId":"1575432072","note":["Gesehen am 23.05.2018"]} 
SRT |a MOUSTAKISCPLANNINGBE3120